{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:49:04Z","timestamp":1792676944176,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010174","name":"University of Colorado","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010174","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ecl.2025.03.013","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T23:35:52Z","timestamp":1749512152000},"page":"443-453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Medullary Thyroid Cancer"],"prefix":"10.1016","volume":"54","author":[{"given":"Amanda","family":"La Greca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Haugen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ecl.2025.03.013_bib1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/jcp.19.2.114","article-title":"Histogenesis of medullary carcinoma of the thyroid","volume":"19","author":"Williams","year":"1966","journal-title":"J Clin Pathol"},{"issue":"2","key":"10.1016\/j.ecl.2025.03.013_bib2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ecl.2022.02.001","article-title":"Novel therapeutics and treatment strategies for medullary thyroid cancer","volume":"51","author":"Walgama","year":"2022","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"13","key":"10.1016\/j.ecl.2025.03.013_bib3","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jama.2017.2719","article-title":"Trends in thyroid cancer incidence and mortality in the United States, 1974-2013","volume":"317","author":"Lim","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ecl.2025.03.013_bib4","doi-asserted-by":"crossref","first-page":"E109","DOI":"10.1210\/jc.2010-0959","article-title":"The prevalence of occult medullary thyroid carcinoma at autopsy","volume":"96","author":"Valle","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ecl.2025.03.013_bib5","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1002\/cncr.22244","article-title":"Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases","volume":"107","author":"Roman","year":"2006","journal-title":"Cancer"},{"issue":"6428","key":"10.1016\/j.ecl.2025.03.013_bib6","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/363458a0","article-title":"Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A","volume":"363","author":"Mulligan","year":"1993","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ecl.2025.03.013_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/genes10090698","article-title":"Twenty-five years experience on RET genetic screening on hereditary MTC: an update on the prevalence of germline RET mutations","volume":"10","author":"Elisei","year":"2019","journal-title":"Genes (Basel)"},{"issue":"1","key":"10.1016\/j.ecl.2025.03.013_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13010094","article-title":"Impact of advanced age on the clinical presentation and outcome of sporadic medullary thyroid carcinoma","volume":"13","author":"Matrone","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.ecl.2025.03.013_bib9","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1139::AID-CNCR26>3.0.CO;2-Z","article-title":"Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems","volume":"88","author":"Kebebew","year":"2000","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ecl.2025.03.013_bib10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00005792-198411000-00001","article-title":"Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients","volume":"63","author":"Saad","year":"1984","journal-title":"Medicine (Baltim)"},{"issue":"8","key":"10.1016\/j.ecl.2025.03.013_bib11","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/(SICI)1097-0142(19960415)77:8<1556::AID-CNCR20>3.0.CO;2-Y","article-title":"Multivariate analysis of patients with medullary thyroid carcinoma. Prognostic significance and impact on treatment of clinical and pathologic variables","volume":"77","author":"Dottorini","year":"1996","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.ecl.2025.03.013_bib12","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1007\/s00268-007-9185-1","article-title":"Increased risk of lymph node metastasis in multifocal hereditary and sporadic medullary thyroid cancer","volume":"31","author":"Machens","year":"2007","journal-title":"World J Surg"},{"issue":"6","key":"10.1016\/j.ecl.2025.03.013_bib13","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"issue":"6","key":"10.1016\/j.ecl.2025.03.013_bib14","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.clon.2010.05.002","article-title":"Medullary thyroid carcinoma","volume":"22","author":"Pacini","year":"2010","journal-title":"Clin Oncol"},{"issue":"6","key":"10.1016\/j.ecl.2025.03.013_bib15","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1089\/thy.2005.15.618","article-title":"Ectopic adrenocorticotropic hormone-syndrome in medullary carcinoma of the thyroid: a retrospective analysis and review of the literature","volume":"15","author":"Barbosa","year":"2005","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.ecl.2025.03.013_bib16","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1210\/jc.2006-1590","article-title":"Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules","volume":"92","author":"Costante","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2025.03.013_bib17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archsurg.142.3.289","article-title":"Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression: a multivariate analysis","volume":"142","author":"Machens","year":"2007","journal-title":"Arch Surg"},{"issue":"2","key":"10.1016\/j.ecl.2025.03.013_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1530\/EJE-21-0313","article-title":"Ultrasound features and risk stratification systems to identify medullary thyroid carcinoma","volume":"185","author":"Matrone","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.ecl.2025.03.013_bib19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/cen.12563","article-title":"Detection rate of FNA cytology in medullary thyroid carcinoma: a meta-analysis","volume":"82","author":"Trimboli","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.ecl.2025.03.013_bib20","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1210\/jc.2011-2033","article-title":"Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer","volume":"97","author":"Colombo","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ecl.2025.03.013_bib21","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1089\/thy.2022.0189","article-title":"Preoperative identification of medullary thyroid carcinoma (MTC): clinical validation of the afirma MTC RNA-sequencing classifier","volume":"32","author":"Randolph","year":"2022","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.ecl.2025.03.013_bib22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng0194-70","article-title":"Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC","volume":"6","author":"Mulligan","year":"1994","journal-title":"Nat Genet"},{"issue":"6461","key":"10.1016\/j.ecl.2025.03.013_bib23","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/367375a0","article-title":"A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma","volume":"367","author":"Hofstra","year":"1994","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ecl.2025.03.013_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14051272","article-title":"Molecular imaging and theragnostics of thyroid cancers","volume":"14","author":"Giovanella","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.ecl.2025.03.013_bib29","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1089\/thy.2016.0255","article-title":"Multifocality in sporadic medullary thyroid carcinoma: an international multicenter study","volume":"26","author":"Essig","year":"2016","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.ecl.2025.03.013_bib25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-2265.1996.681503.x","article-title":"Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma","volume":"44","author":"Marsh","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2025.03.013_bib26","series-title":"AJCC cancer staging manual","first-page":"891","author":"Rosen","year":"2018"},{"issue":"10","key":"10.1016\/j.ecl.2025.03.013_bib27","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1097\/PAS.0000000000001505","article-title":"A proposed grading scheme for medullary thyroid carcinoma based on proliferative activity (Ki-67 and mitotic count) and coagulative necrosis","volume":"44","author":"Fuchs","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.ecl.2025.03.013_bib28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1200\/JCO.21.01329","article-title":"International medullary thyroid carcinoma grading system: a validated grading system for medullary thyroid carcinoma","volume":"40","author":"Xu","year":"2022","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ecl.2025.03.013_bib30","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4103\/IJPM.IJPM_478_17","article-title":"C-cell hyperplasia in sporadic and familial medullary thyroid carcinoma","volume":"61","author":"Yadav","year":"2018","journal-title":"Indian J Pathol Microbiol"},{"issue":"6","key":"10.1016\/j.ecl.2025.03.013_bib31","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1210\/jc.2009-2368","article-title":"Biomarker-based risk stratification for previously untreated medullary thyroid cancer","volume":"95","author":"Machens","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2025.03.013_bib32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/thy.2022.0506","article-title":"Neoadjuvant selective RET inhibitor for medullary thyroid cancer: a case series","volume":"33","author":"Contrera","year":"2023","journal-title":"Thyroid"},{"key":"10.1016\/j.ecl.2025.03.013_bib33","series-title":"Selpercatinib befire surgery for the treatment of RET-altered thyroid cancer","year":"2023"},{"issue":"1","key":"10.1016\/j.ecl.2025.03.013_bib34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/172460089400900104","article-title":"Disappearance rate of serum calcitonin after total thyroidectomy for medullary thyroid carcinoma","volume":"9","author":"Fugazzola","year":"1994","journal-title":"Int J Biol Markers"},{"issue":"4","key":"10.1016\/j.ecl.2025.03.013_bib35","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1365-2265.2009.03666.x","article-title":"Calcitonin and carcinoembryonic antigen doubling times as prognostic factors in medullary thyroid carcinoma: a structured meta-analysis","volume":"72","author":"Meijer","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.ecl.2025.03.013_bib36","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/thy.1996.6.305","article-title":"Medullary thyroid cancer: analyses of survival and prognostic factors and the role of radiation therapy in local control","volume":"6","author":"Brierley","year":"1996","journal-title":"Thyroid"},{"issue":"9","key":"10.1016\/j.ecl.2025.03.013_bib37","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa2005651","article-title":"Efficacy of selpercatinib in RET-altered thyroid cancers","volume":"383","author":"Wirth","year":"2020","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.ecl.2025.03.013_bib38","first-page":"7284","article-title":"ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases","volume":"62","author":"Carlomagno","year":"2002","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.ecl.2025.03.013_bib39","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1200\/JCO.2011.35.5040","article-title":"Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial","volume":"30","author":"Wells","year":"2012","journal-title":"J Clin Oncol"},{"issue":"29","key":"10.1016\/j.ecl.2025.03.013_bib40","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1200\/JCO.2012.48.4659","article-title":"Cabozantinib in progressive medullary thyroid cancer","volume":"31","author":"Elisei","year":"2013","journal-title":"J Clin Oncol"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852925000350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852925000350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T23:02:18Z","timestamp":1753484538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852925000350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0889852925000350"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2025.03.013","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medullary Thyroid Cancer","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2025.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}